Review Article

You have full text access to this OnlineOpen article

Central nervous system effects of natural and synthetic glucocorticoids

Pierluigi Fietta MD ^1,*,
Pieranna Fietta MD ²,
Giovanni Delsante MD ²

Article first published online: 23 SEP 2009

DOI: 10.1111/j.1440-1819.2009.02005.x

Issue

Psychiatry and Clinical Neurosciences

Volume 63, Issue 5, pages 613–622, October 2009

Additional Information

How to Cite

Fietta, P., Fietta, P. and Delsante, G. (2009), Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry and Clinical Neurosciences, 63: 613–622. doi: 10.1111/j.1440-1819.2009.02005.x

Author Information

¹
Psychiatry Department, Hospital of Lodi, Lodi and
²
Medical Department 2, Rheumatology and Internal Medicine Unit, Hospital and University of Parma, Parma, Italy

^* Pierluigi Fietta, MD, Dipartimento di Psichiatria, Azienda Ospedaliera di Lodi, Via Fleming, n. 1, 26849 Lodi, Italy. Email: pierluigi.fietta@ao.lodi.it

Publication History

Issue published online: 23 SEP 2009
Article first published online: 23 SEP 2009
Received 31 August 2008; revised 3 May 2009; accepted 19 May 2009.

ARTICLE TOOLS

View Full Article (HTML) Get PDF (93K)

REFERENCES

1
Fietta P, Fietta P. Glucocorticoids and brain functions. Riv. Biol. 2007; 100: 403–418.
- PubMed,
- Web of Science® Times Cited: 1
2
Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr. Rev. 2000; 21: 55–89.
3
van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. Q. J. Med. 2000; 93: 105–111.
- CrossRef
4
McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr. Opin. Rheumatol. 2008; 20: 131–137.
5
Sirois F. Steroid psychosis: A review. Gen. Hosp. Psychiatry 2003; 25: 27–33.
6
Joëls M, de Kloet ER. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 1992; 15: 25–30.
7
de Kloet ER, de Jong IE, Oitzl MS. Neuropharmacology of glucocorticoids: Focus on emotion, cognition and cocaine. Eur. J. Pharmacol. 2008; 585: 473–482.
8
Drake AJ, Tang JI, Nyirenda MJ. Mechanism underlying the role of glucocorticoids in the early life programming of adult disease. Clin. Sci. (Lond) 2007; 113: 219–232.
9
Seckl JR. Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction. Prog. Brain Res. 2008; 167: 17–34.
10
Seckl JR, Meaney MJ. Glucocorticoid programming. Ann. N. Y. Acad. Sci. 2004; 1032: 63–84.
Direct Link:
11
Dallman MF, Warne JP, Foster MT, Pecoraro NC. Glucocorticoids and insulin both modulate caloric intake through actions on the brain. J. Physiol. 2007; 583: 431–436.
Direct Link:
12
Prinz PN, Bailey SL, Woods DL. Sleep impairments in healthy seniors: Roles of stress, cortisol, and interleukin-1 beta. Chronobiol. Int. 2000; 17: 391–404.
13
Stone EA, Lin Y. An anti-immobility effect of exogenous corticosterone in mice. Eur. J. Pharmacol. 2008; 580: 135–142.
14
Murray F, Smith DW, Hutson PH. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharmacol. 2008; 583: 115–127.
15
Het S, Wolf OT. Mood changes in response to psychosocial stress in healthy young women: Effects of pretreatment with cortisol. Behav. Neurosci. 2007; 12: 11–20.
- CrossRef,
- Web of Science® Times Cited: 24
16
Kelly WF. Psychiatric aspects of Cushing's syndrome. Q. J. Med. 1996; 89: 543–551.
- PubMed,
- Web of Science® Times Cited: 28
17
Dorn LD, Burgess ES, Dubbert B et al. Psychopathology in patients with endogenous Cushing's syndrome: ‘Atypical’ or melancholic features. Clin. Endocrinol. (Oxf) 1995; 43: 433–442.
Direct Link:
18
Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am. J. Psychiatry 1985; 142: 911–916.
- PubMed,
- Web of Science® Times Cited: 93
19
Hudson JI, Hudson MS, Griffing GT, Melby JC, Pope HG Jr. Phenomenology and family history of affective disorder in Cushing's disease. Am. J. Psychiatry 1987; 144: 951–953.
- PubMed,
- Web of Science® Times Cited: 27
20
Kelly WF, Kelly MJ, Faragher B. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin. Endocrinol. (Oxf) 1996; 45: 715–720.
Direct Link:
21
Lupien SJ, Wilkinson CW, Brière S et al. The modulatory effects of corticosteroids on cognition: Studies in young human populations. Psychoneuroendocrinology 2002; 27: 401–416.
22
Matsui M, Tanaka K, Yonezawa M, Kurachi M. Activation of the prefrontal cortex during memory learning: Near-infrared spectroscopy study. Psychiatry Clin. Neurosci. 2007; 61: 31–38.
Direct Link:
23
Ferguson D, Sapolsky R. Mineralcorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory. J. Neurosci. 2007; 27: 8046–8052.
24
Brunner R, Schaefer D, Hess K, Parzer P, Resh F, Schwab S. Effect of high-dose cortisol on memory function. Ann. N. Y. Acad. Sci. 2006; 1071: 434–437.
Direct Link:
25
Wolf OT, Convit A, McHugh PF et al. Cortisol differentially affects memory in young and elderly men. Behav. Neurosci. 2001; 115: 1002–1011.
26
Newcomer JW, Selke G, Melson AJ et al. Dose- and time-dependent cortisol-induced decrease in memory performance in humans. Abstr. Soc. Neurosci. 1997; 23: 2121.
27
Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom. Med. 2001; 63: 985–993.
- PubMed,
- Web of Science® Times Cited: 57
28
Mauri M, Sinforiani E, Bono G et al. Memory impairment in Cushing's disease. Acta Neurol. Scand. 1993; 87: 52–55.
29
Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 1999; 46: 1595–1602.
30
Wolkowitz OM. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994; 19: 233–255.
31
Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J. Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology 1999; 24: 461–483.
32
Curtis JR, Westfall AO, Allison J et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006; 55: 420–426.
Direct Link:
33
Wung PK, Anderson T, Fontaine KR et al. Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis. Arthritis Rheum. 2008; 59: 746–753.
Direct Link:
34
Da Silva JA, Jacobs JW, Kirwan JR et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data. Ann. Rheum. Dis. 2006; 65: 285–293.
35
George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch. Dermatol. 2004; 140: 963–969.
36
Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics 1999; 104: e51.
37
Ling MH, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy. Psychiatric aspects. Arch. Gen. Psychiatry 1981; 38: 471–477.
38
Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J. Affect. Disord. 1983; 5: 319–332.
39
Vanelle JM, Aubin F, Michel F. Psychiatric complications of corticotherapy. Rev. Prat. 1990; 40: 556–558 (in French).
- PubMed
40
Wada K, Yamada N, Sato T et al. Corticosteroid-induced psychotic and mood disorders: Diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001; 42: 461–466.
41
Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim. Care Companion J. Clin. Psychiatry 2001; 3: 17–21.
42
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin. Proc. 2006; 81: 1361–1367.
43
Bräunig P, Bleistein J, Rao ML. Suicidality and corticosteroid-induced psychosis. Biol. Psychiatry 1989; 26: 209–210.
44
Boston Collaborative Drug Surveillance Programme. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Ther. 1972; 13: 694–698.
- PubMed
45
Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann. Allergy Asthma Immunol. 2004; 92: 500–505.
46
Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest. 1989; 7: 479–491.
47
Hall RC, Popkin MK, Stickney SK, Gardner ER. Presentation of steroid psychoses. J. Nerv. Ment. Dis. 1979; 167: 229–236.
48
Satel SL. Mental status changes in children receiving glucocorticoids. Review of the literature. Clin. Pediatr. (Phila) 1990; 29: 383–388.
49
Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: Adverse reactions are more variable than expected in children. J. Rheumatol. 1998; 25: 1995–2002.
- PubMed,
- Web of Science® Times Cited: 37
50
Stuart FA, Segal TY, Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch. Dis. Child. 2005; 90: 500–506.
51
Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: Case presentations. Int. J. Psychosom. 1990; 37: 57–61.
- PubMed
52
Greeves JA. Rapid-onset steroid psychosis with very low dosage of prednisolone. Lancet 1984; 1: 1119–1120.
53
Wolkowitz OM, Rubinow D, Doran AR et al. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch. Gen. Psychiatry 1990; 47: 963–968.
54
Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996; 21: 25–31.
55
Brown SE, Suppes T, Khan DA, Carmody TJ 3rd. Mood changes during prednisone bursts in outpatients with asthma. J. Clin. Psychopharmacol. 2002; 22: 55–61.
56
Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: Incidence, diagnosis and management. Drug Saf. 2000; 22: 111–122.
57
Brown ES, Beard L, Frol AB, Rush AJ. Effect of two prednisone exposures on mood and declarative memory. Neurobiol. Learn. Mem. 2006; 86: 28–34.
58
Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 2008; 33: 395–403.
59
López-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: A possible role of serum albumin level. Ann. Rheum. Dis. 2002; 61: 562–563.
60
Waber DP, Carpentieri SC, Klar N et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J. Pediatr. Hematol. Oncol. 2000; 22: 206–213.
61
Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B. Effects of chronic prednisone therapy on mood and memory. J. Affect. Disord. 2007; 99: 279–283.
62
Wada K, Yamada N, Suzyki H, Lee Y, Kuroda S. Recurrent cases of corticosteroid-induced mood disorder: Clinical characteristics and treatment. J. Clin. Psychiatry 2000; 61: 261–267.
63
Baloch N. ‘Steroid psychosis’: A case report. Br. J. Psychiatry 1974; 124: 545–546.
64
Robinson DE, Harrison-Hansley E, Spencer RF. Steroid psychosis after an intra-articular injection. Ann. Rheum. Dis. 2000; 59: 927.
65
Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 1994; 14: 2047–2053.
- PubMed,
- Web of Science® Times Cited: 256
66
Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 1996; 47: 1396–1402.
- PubMed,
- Web of Science® Times Cited: 95
67
Brown ES, Woolston DJ, Frol AB et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 2004; 55: 538–545.
68
Brown ES, Woolston DJ, Frol AB. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol. Psychiatry 2008; 63: 705–709.
69
Heffelfinger AK, Newcomer JW. Glucocorticoid effects on memory function over the human life span. Dev. Psychopathol. 2001; 13: 491–513.
70
Varney NR, Alexander B, MacIndoe JH. Reversible steroid dementia in patients without steroid psychosis. Am. J. Psychiatry 1984; 141: 369–372.
- PubMed,
- Web of Science® Times Cited: 84
71
Sacks O, Shulman M. Steroid dementia: An overlooked diagnosis?. Neurology 2005; 64: 707–709.
72
Wolkowitz OM, Lupien SJ, Bigler ED, Levin RB, Canick J. The ‘steroid dementia syndrome’: An unrecognized complication of glucocorticoid treatment. Ann. N. Y. Acad. Sci. 2004; 1032: 191–194.
Direct Link:
73
Wolkowitz OM, Lupien SJ, Bigler ED. The ‘steroid dementia syndrome’: A possible model of human glucocorticoid neurotoxicity. Neurocase 2007; 13: 189–200.
74
Newcomer JW, Selke G, Melson AK et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry 1999; 56: 527–533.
75
Coluccia D, Wolf OT, Kollias S, Roozendaal B, Forster A, de Quervain DJ. Glucocorticoid therapy-induced memory deficits: Acute versus chronic effects. J. Neurosci. 2008; 26: 3474–3478.
76
Sutor B, Wells LA, Rummans TA. Steroid-induced depressive psychosis responsive to electroconvulsive therapy. Convuls. Ther. 1996; 12: 104–107.
- PubMed,
- Web of Science® Times Cited: 7
77
Brown ES, Wolfshohl J, Shad MU, Vazquez M, Osuji IJ. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. Neuropsychopharmacology 2008; 33: 2376–2383.
78
Preda A, Fazeli A, McKay BG, Bowers MB Jr, Mazure CM. Lamotrigine as prophylaxis against steroid-induced mania. J. Clin. Psychiatry 1999; 60: 708–709.
79
Brown ES, Stuard G, Liggin JD et al. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol. Psychiatry 2005; 57: 543–548.
80
Brown ES, Vazquez M, Nakamura A. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol. Psychiatry 2008; 64: 727–729.
81
Brown ES, Frol AB, Khan DA, Larkin GL, Bret ME. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur. Psychiatry 2007; 22: 448–452.
82
Terao T, Yoshimura R, Shiratuchi T, Abe K. Effects of lithium on steroid-induced depression. Biol. Psychiatry 1997; 41: 1225–1226.
83
Ito M, Onose M, Yamada T, Onishi H, Fujisawa S, Kanamori H. Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: A case report. Jpn. J. Clin. Oncol. 2003; 33: 538–540.
84
Hall RC, Popkin MK, Kirkpatrick B. Tryciclic exacerbation of steroid psychosis. J. Nerv. Ment. Dis. 1987; 166: 738–742.
- PubMed,
- Web of Science® Times Cited: 47
85
Beshay H, Pumariega AJ. Sertraline treatment of mood disorder associated with prednisone: A case report. J. Child. Adolesc. Pharmacol. 1998; 8: 187–193.
86
Ros LT. Symptomatic depression after long-term steroid treatment: A case report. Afr. J. Med. Med. Sci. 2004; 33: 263–265.
- PubMed
87
Ismail M, Lyster G. Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Ir. Med. J. 2002; 95: 18–19.
- PubMed
88
Ahmad M, Rasul FM. Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am. J. Emerg. Med. 1999; 17: 735.
89
Goldman LS, Goveas J. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics 2002; 43: 495–497.
90
Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M. An open-label trial of olanzapine for corticosteroid-induced symptoms. J. Affect. Disord. 2004; 83: 277–281.
91
DeSilva CC, Nurse MC, Vokey K. Steroid-induced psychosis treated with risperidone. Can. J. Psychiatry 2002; 47: 388–389.
- PubMed,
- Web of Science® Times Cited: 10
92
Kato O, Misawa H. Steroid-induced psychosis treated with valproic acid and risperidone in a patient with systemic lupus erythematosus. Prim. Care Companion J. Clin. Psychiatry 2005; 7: 312.
- CrossRef,
- PubMed
93
Ingram DG, Hagemann TM. Promethazine treatment of steroid-induced psychosis in a child. Ann. Pharmacother. 2003; 37: 1036–1039.
94
Fleming PS, Flood TR. Interesting case: Steroid-induced psychosis after orthognathic surgery. Br. J. Oral. Maxillofac. Surg. 2005; 43: 419.
- CrossRef,
- PubMed
95
Kramer TM, Cottingham EM. Risperidone in the treatment of steroid-induced psychosis. J. Child Adolesc. Psychopharmacol. 1999; 9: 315–316.
96
Hergüner S, Bilge I, Yavuz Yilmaz A, Tüzün DU. Steroid-induced psychosis in an adolescent: Treatment and prophylaxis with risperidone. Turk. J. Pediatr. 2006; 48: 244–247.
- PubMed,
- Web of Science® Times Cited: 2
97
Jeanneteau F, Garabedian MJ, Chao MV. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc. Natl Acad. Sci. USA 2008; 105: 4862–4867.
98
Olijslagers JE, de Kloet ER, Elgersma Y, van Woerden GM, Joëls M, Karst H. Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralcorticoid receptors. Eur. J. Neurosci. 2008; 27: 2542–2550.
Direct Link:
99
Abrahám IM, Harkany T, Horvath KM, Luiten PG. Action of glucocorticoids on survival of nerve cells: Promoting neurodegeneration or neuroprotection? J. Neuroendocrinol. 2001; 13: 749–760.
Direct Link:
100
De Leon MJ, McRae T, Rusinek H et al. Cortisol reduces hippocampal glucose metabolism in normal elderly but not in Alzheimer's disease. J. Clin. Endocrinol. Metab. 1997; 82: 3251–3259.
101
Gilad GM, Rabey JM, Gilad VH. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interaction in stress. Life Sci. 1987; 40: 2401–2408.
102
McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol. Psychiatry 1997; 2: 255–262.
103
Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders. Neuropsychopharmacology 1999; 21: 474–484.
104
de Quervain DJ, Henke K, Aerni A et al. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur. J. Neurosci. 2003; 17: 1296–1302.
Direct Link:

View Full Article (HTML) Get PDF (93K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Central nervous system effects of natural and synthetic glucocorticoids

Psychiatry and Clinical Neurosciences

How to Cite

Author Information

Publication History

ARTICLE TOOLS

REFERENCES

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Central nervous system effects of natural and synthetic glucocorticoids

Psychiatry and Clinical Neurosciences

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

REFERENCES

More content like this